Drug interactions
Bazedoxifene-conjugated estrogens + Bemiparin
Severity: Major
Bazedoxifene-conjugated estrogens and Bemiparin: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Bemiparin is a low-molecular-weight heparin used to treat or prevent thrombosis. Conjugated estrogens with bazedoxifene increase venous thromboembolism risk, which is the very condition being treated, so the indication itself is a concern.
What this interaction means in plain words
Bazedoxifene-conjugated estrogens and Bemiparin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Estrogenic prothrombotic effects oppose anticoagulant therapy; this is a clinical opposition rather than a direct interaction.
What to do
Avoid starting this hormone product in patients with active or recent thromboembolism needing anticoagulation. If prophylactic bemiparin is only short term, reassess hormone therapy need and risk.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bazedoxifene-conjugated estrogens and Bemiparin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Bazedoxifene-conjugated estrogens
- Anastrozole + Bazedoxifene-conjugated estrogens Contraindicated
- Bazedoxifene-conjugated estrogens + Ospemifene Contraindicated
- Antithrombin alfa + Bazedoxifene-conjugated estrogens Major
- Antithrombin iii + Bazedoxifene-conjugated estrogens Major
- Bazedoxifene-conjugated estrogens + Carbamazepine Major
- Bazedoxifene-conjugated estrogens + Dalteparin Major
Frequently asked questions
Can I take Bazedoxifene-conjugated estrogens with Bemiparin?
MediHelp rates the interaction as major. Bazedoxifene-conjugated estrogens and Bemiparin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Bemiparin is a low-molecular-weight heparin used to treat or prevent thrombosis. Conjugated estrogens with bazedoxifene increase venous thromboembolism risk, which is the very condition being treated, so the indication itself is a concern.
How serious is the interaction between Bazedoxifene-conjugated estrogens and Bemiparin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting this hormone product in patients with active or recent thromboembolism needing anticoagulation. If prophylactic bemiparin is only short term, reassess hormone therapy need and risk.
What other medicines interact with Bazedoxifene-conjugated estrogens?
MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
